NCT03510650View on ClinicalTrials.gov

Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

June 26, 2022

Study Completion Date

December 26, 2022

Conditions

Hemophagocytic Lymphohistiocytosis

Trial Locations (1)

13353

Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors

lead

Charite University, Berlin, Germany

OTHER

NCT03510650 - Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU) | Biotech Hunter | Biotech Hunter